Navigation Links
Mesa Labs Declares Quarterly Dividend
Date:8/11/2009

LAKEWOOD, Colo., Aug. 11 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today announced that its Board of Directors has declared a regular quarterly cash dividend of 10 cents per share of common stock, payable on September 15, 2009 to shareholders of record at the close of business on August 28, 2009.

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties. The Company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2009 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Nu Skin Enterprises Declares Quarterly Dividend of $0.115
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. BD Board Declares Dividend
4. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program
5. Mylan Declares Quarterly Preferred Stock Dividend
6. CCA Industries, Inc. Declares $0.07 Dividend For The Third Quarter
7. Lilly Declares Third-Quarter Dividend
8. Weight Watchers Declares Quarterly Dividend
9. The Ensign Group Declares Quarterly Dividend
10. BioMed Realty Trust Declares Second Quarter 2009 Common Stock and Preferred Stock Dividends
11. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... The ... Canyon Ranch to its recently formed Corporate Roundtable, a group of individuals ... and a sustainable world. , Canyon Ranch is a unique collection of lifestyle-based ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the industry’s ... medication management services are delivered. Based on industry research and market feedback, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Driving Dynamics Inc., announced today it ... Training Industry Inc. as part of its mission to continually monitor the training marketplace ... first annual 2017 Top 20 Health and Safety Training Companies list was based on ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... by a neurosurgeon, has received a big bump in sales after recently ... is currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, RevNutrition.com and ...
(Date:9/19/2017)... New York (PRWEB) , ... September 19, 2017 , ... ... dentist, Dr. Andrew Sami, was recently named one of the best dentists in America ... lifestyle magazine for dental professionals nationwide. Every fall, the magazine features the best 40 ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... ORANGEBURG, N.Y. , Sept. 6, 2017   PDI ... today announced it will host an educational session focused ... line-associated bloodstream infection (CLABSI) prevention at the 2017 Annual ... meeting, which will take place at the ... Arizona from Sept. 16-19, will also feature ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
Breaking Medicine Technology: